Latest Conference Articles

The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.

Pembrolizumab Plus Chemo Generates Favorable OS Trend in Endometrial Cancer

March 16th 2024, 6:16pm

SGO Annual Meeting

The addition of pembrolizumab to chemotherapy led to a favorable overall survival benefit vs chemotherapy plus placebo in endometrial cancer.

Social Determinants of Health Linked With Varying Cervical Cancer Rates in the US

March 16th 2024, 5:42pm

SGO Annual Meeting

Social determinants of health were associated with geographical variations in the rates of cervical cancer in the United States.

Dr Liu on Surgical Outcomes Following Radiation and Chemotherapy in Rectal Cancer

March 16th 2024, 2:15pm

ACRO Summit

I-Chia (Daniel) Liu, MD, discusses surgical and local control outcomes following short-course radiation therapy and chemotherapy for rectal cancer.

Mutter Discusses Partial Breast Irradiation in Low-Risk Breast Cancer

March 15th 2024, 11:11pm

ACRO Summit

Robert W. Mutter, MD, discusses the nuances of partial breast irradiation in early-stage breast cancer.

Post-Hoc Analysis Shows Dose-Escalated Radiation is Safe and Efficacious in Intrahepatic Cholangiocarcinoma

March 15th 2024, 10:36pm

ACRO Summit

A post-hoc analysis showed dose escalation of radiation therapy was safe and elicited similar efficacy in intrahepatic cholangiocarcinoma.

Advanced Radiation Techniques Could Aid in Cardiac Sparing in Lung, Breast, and Esophageal Cancer Treatment

March 15th 2024, 10:16pm

ACRO Summit

Charles B. Simone II, MD, FASTRO, FACRO, discusses advanced radiation techniques that could reduce cardiac toxicities.

Dr Knight on the Investigation of Patients With Brain-Metastatic Prostate Adenocarcinoma

March 15th 2024, 7:42pm

ACRO Summit

James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.

Dr Efstathiou on the Role of Tri-Modality Therapy in MIBC

March 15th 2024, 7:38pm

ACRO Summit

Jason Efstathiou, MD, DPhil, discusses the role of tri-modality therapy in patients with muscle-invasive bladder cancer.

Dr Zaha on the Risk of Cardiovascular Toxicity in Patients With Lung Cancer

March 15th 2024, 7:38pm

ACRO Summit

Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation.

Deep Dive into a Case Study on Liver-Sparing TBI Plus Helical Tomotherapy in Relapsed Pre-B Cell ALL

March 15th 2024, 6:30pm

ACRO Summit

A case study of a patient with pre-B cell acute lymphoblastic leukemia showed helical tomotherapy with IMRT-based TBI is a viable option for organ sparing.

Navigating Career Crossroads: Insights from Hope Rugo’s Journey as a Woman in Oncology

March 15th 2024, 5:47pm

PER® Miami Breast Cancer Conference

Hope S. Rugo, MD, draws on her own journey as a woman in oncology to provide insights on navigating career transitions and building support networks.

Graff Highlights the Importance of Perseverance and Self-Advocacy as a Woman in Oncology

March 15th 2024, 1:00pm

PER® Miami Breast Cancer Conference

Stephanie L. Graff, MD, shares her journey to becoming an oncologist, advice for work-life balance, and ways to confront gender bias in medicine.

QOL Remains a Key Goal of the Use of Radiation in Rectal Cancer

March 14th 2024, 10:00pm

ACRO Summit

Nina Sanford, MD, discusses how radiation could help improve QOL for patients with rectal cancer and situations when radiation or surgery could be omitted.

Retrospective Study Shows Neoadjuvant SCRT is Associated With Optimal Surgical Outcomes in Rectal Cancer

March 14th 2024, 9:55pm

ACRO Summit

Prolonged duration from neoadjuvant SCRT to surgery did not increase the risk of poor mesorectum specimen quality or post-operative morbidity in rectal cancer.

Dr Singh on the Utility of Radiation Therapy in Lung Cancer

March 14th 2024, 9:42pm

ACRO Summit

Raj Singh, MD, discusses radiation therapy in patients with metastatic lung cancer, highlighting the evolution of treatment within this landscape.

Dr Franco on the Integration of Immunotherapy Treatment in Endometrial Cancer

March 14th 2024, 9:36pm

ACRO Summit

Idalid Franco, MD, MPH, discusses the use of radiation therapy and immunomodulatory agents in the treatment of endometrial cancer.

Brown Details the Evolving Role of PCI and HA-PCI in Small Cell Lung Cancer

March 14th 2024, 8:30pm

ACRO Summit

Paul D. Brown, MD, gives a history of prophylactic cranial irradiation in small cell lung cancer and describes its standing in the treatment paradigm.

Dr Zhang on Topics of Ongoing Debate Within Prostate Cancer

March 12th 2024, 7:42pm

US Prostate Cancer Conference (USPCC)

Tian Zhang, MD, MHS, discusses areas of ongoing debate regarding prostate cancer management.

TNO155 Plus Spartalizumab or Ribociclib Elicits Disease Control, Is Safe in Advanced Solid Tumors

March 12th 2024, 5:46pm

ESMO Targeted Anticancer Therapies Congress

TNO155 plus spartalizumab or ribociclib was well tolerated and demonstrated disease control in patients with advanced solid tumors.

Dr Graff on the Trajectory of Her Career in Breast Cancer

March 11th 2024, 10:14pm

PER® Miami Breast Cancer Conference

Stephanie L. Graff, MD, discusses the trajectory of her career growth in breast oncology and explains how different factors can play a role in an oncologist’s career path.